Growth Capital • Medical Products

EW Healthcare Partners Invests In Venus Concept

On July 13, 2017, growth capital firm EW Healthcare Partners invested in medical products company Venus Concept

Investment Context
  • This is EW Healthcare Partners’ 24th transaction in the Medical Products sector.
  • This is EW Healthcare Partners’ 1st transaction in Canada.
  • This is EW Healthcare Partners’ 1st transaction in Ontario.
Investment Fate
  • Venus Concept went public in 2019.

Explore All 336 Growth Capital Medical Products Deals - Search the Database Free


Investment Summary

Date July 13, 2017
Target Venus Concept
Sector Medical Products
Investor(s) EW Healthcare Partners
Deal Type Growth Capital

Target Company

Venus Concept

Toronto, Ontario, Canada
Venus Concept is a medical technology company that develops, commercializes, and delivers safe, efficacious, and easy-to-use aesthetic technologies and related practice enhancement services in a unique, industry-disruptive subscription-based business model. Venus Concept was founded in 2002 and is based in Toronto, Ontario.
Explore More Deals

Browse All 215,156 Deals

FILTER BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Search Free

Investor Overview 1

Investor

EW Healthcare Partners

Investor Investor Investor Investor Investor


Category Growth Capital Firm
Founded 1985
PE ASSETS 3.0B USD
Size Large
Type Sector Focused
DESCRIPTION

Essex Woodlands Health Ventures is a growth equity and venture capital specialist investment firm focused on opportunities across the healthcare sector. Specific areas of interest include biotechnology, pharmaceuticals, medical devices, and healthcare services/IT. Historically, Essex invested primarily in early and later-stage situations; however, today the firm also makes growth capital investments between $20 - $60 million in companies valued between $50 - $250 million, as well as private investments in public entities (PIPEs). Essex Woodlands was formed in 1985 and offices in Palo Alto, California; New York City; Houston, Texas; Shanghai and London.


Deal Context for Investor #
Overall 53 of 59
Sector: Medical Products 24 of 24
Type: Growth Capital 9 of 10
State: Ontario 1 of 1
Country: Canada 1 of 1
Year: 2017 2 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2017-05-15 Key Health

Westlake Village, California, United States

Key Health manages a California based radiology and neurodiagnostic provider network that assists the workers' compensation and personal injury segments of the diagnostic services market. Key Health is based in Westlake Village, California.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2017-08-04 TearScience

Morrisville, North Carolina, United States

TearScience is a medical device manufacturer dedicated to evaluating meibomian gland health and treating meibomian gland dysfunction (MGD). TearScience was founded in 2005 and is based in Morrisville, North Carolina.

Sell -